Skip to content

The Mindful Compassion Program Integrated with Body-Mind-Spirit Empowerment for Reducing Depression in Lung Cancer Patient-Caregiver Dyads.

Fei-Hsiu Hsiao, Chao-Chi Ho, Chong-Jen Yu, Jin-Yuan Shih, Zhong-Zhe Lin, Feng-Ying Huang, Yu-Ting Chen, Chia-Chen Hsieh

Psychosocial Intervention 2025 DOI: 10.5093/pi2025a1 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 56
Population Lung cancer patients and their caregivers
Intervention Mindful compassion program
Duration 14-month follow-up
Topics Anxiety Depression
Keywords Depressive symptoms Dyadic depression program Mindfulness awareness Self-compassion
Citations 4
Key findings The dyadic mindful compassion program led to a significant reduction in depressive symptoms in lung cancer patients, with greater benefits for younger patients and those with higher baseline quality-of-life symptom distress, and improvements in mindfulness and self-compassion contributed to reduced depression.

Abstract

Objective: This study compared the long-term effects of a mindful compassion program on improving depression in lung cancer patients, both in patient-caregiver dyads and in patient-only groups, and examined the moderating roles of anxiety and quality of life (QOL).

Method: Participants consisted of 56 dyads, who were randomly assigned to either the dyadic or patient-only groups. Data collection included various assessments at different time points: baseline (T0), end of intervention (T1), and follow-up at the 5th month (T2), 8th month (T3), and 14th month (T4).

Results: Patients in the dyadic group experienced a significant reduction in depressive symptoms. The dyadic intervention was particularly beneficial for younger patients and those with higher baseline QOL symptom distress. Improvements in patients' mindfulness and self-compassion contributed to reduced depression by enhancing general health and lowering anxiety. Additionally, caregivers' self-compassion played a role in reducing patients' depression by improving patients' QOL functioning and decreasing anxiety.

Conclusions: Mindfulness and compassion interventions, whether provided dyadically or individually, can be tailored to each patient's specific condition.

Comparable studies

Other randomized controlled trials on depression, most cited first.

Study Year Design Participants
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Subjects with DSM-IV major depression (treatment resistant) 2006 Randomized, placebo-controlled, double-blind crossover study n = 18
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics